Descripción del proyecto

Stroke - recientes

Circuit Class Therapy for Improving Mobility After Stroke [Cochrane Corner]
25/9/2017
Coralie English, Susan Hillier, Elizabeth Lynch
ver resumen

Why Is It Worthwhile to Get Involved in Stroke Organizations? [InterSECT]
25/9/2017
Antje Schmidt, Mira Katan, Else Charlotte Sandset
ver resumen

History of Aneurysmal Spontaneous Subarachnoid Hemorrhage [Stroke History]
25/9/2017
Kristiȷonas Milinis, Ankur Thapar, Kevin O’Neill, Alun Huw Davies
ver resumen

Defining Optimal Brain Health in Adults: A Presidential Advisory From the American Heart Association/American Stroke Association [AHA/ASA Presidential Advisory]
25/9/2017
Philip B. Gorelick, Karen L. Furie, Costantino Iadecola, Eric E. Smith, Salina P. Waddy, Donald M. Lloyd-Jones, Hee-Joon Bae, Mary Ann Bauman, Martin Dichgans, Pamela W. Duncan, Meighan Girgus, Virginia J. Howard, Ronald M. Lazar, Sudha Seshadri, Fernando D. Testai, Stephen van Gaal, Kristine Yaffe, Hank Wasiak, Charlotte Zerna
ver resumen
Cognitive function is an important component of aging and predicts quality of life, functional independence, and risk of institutionalization. Advances in our understanding of the role of cardiovascular risks have shown them to be closely associated with cognitive impairment and dementia. Because many cardiovascular risks are modifiable, it may be possible to maintain brain health and to prevent dementia in later life. The purpose of this American Heart Association (AHA)/American Stroke Association presidential advisory is to provide an initial definition of optimal brain health in adults and guidance on how to maintain brain health. We identify metrics to define optimal brain health in adults based on inclusion of factors that could be measured, monitored, and modified. From these practical considerations, we identified 7 metrics to define optimal brain health in adults that originated from AHA’s Life’s Simple 7: 4 ideal health behaviors (nonsmoking, physical activity at goal levels, healthy diet consistent with current guideline levels, and body mass index <25 kg/m2) and 3 ideal health factors (untreated blood pressure <120/<80 mm Hg, untreated total cholesterol <200 mg/dL, and fasting blood glucose <100 mg/dL). In addition, in relation to maintenance of cognitive health, we recommend following previously published guidance from the AHA/American Stroke Association, Institute of Medicine, and Alzheimer’s Association that incorporates control of cardiovascular risks and suggest social engagement and other related strategies. We define optimal brain health but recognize that the truly ideal circumstance may be uncommon because there is a continuum of brain health as demonstrated by AHA’s Life’s Simple 7. Therefore, there is opportunity to improve brain health through primordial prevention and other interventions. Furthermore, although cardiovascular risks align well with brain health, we acknowledge that other factors differing from those related to cardiovascular health may drive cognitive health. Defining optimal brain health in adults and its maintenance is consistent with the AHA’s Strategic Impact Goal to improve cardiovascular health of all Americans by 20% and to reduce deaths resulting from cardiovascular disease and stroke by 20% by the year 2020. This work in defining optimal brain health in adults serves to provide the AHA/American Stroke Association with a foundation for a new strategic direction going forward in cardiovascular health promotion and disease prevention.

Letter by Tsuda Regarding Article, “Association of Vegetable Nitrate Intake With Carotid Atherosclerosis and Ischemic Cerebrovascular Disease in Older Women” [Letter to the Editor]
25/9/2017
Kazushi Tsuda
ver resumen

Response by Bondonno et al to Letter Regarding Article, “Association of Vegetable Nitrate Intake With Carotid Atherosclerosis and Ischemic Cerebrovascular Disease in Older Women” [Letter to the Editor]
25/9/2017
Catherine P. Bondonno, Lauren C. Blekkenhorst, Jonathan M. Hodgson
ver resumen

Letter by Li and Chen Regarding Article, “Impact of Thrombus Length on Outcomes After Intra-Arterial Aspiration Thrombectomy in the THERAPY Trial” [Letter to the Editor]
25/9/2017
Tiangui Li, Fang Chen
ver resumen

Response by Yoo et al to Letter Regarding Article, “Impact of Thrombus Length on Outcomes After Intra-Arterial Aspiration Thrombectomy in the THERAPY Trial” [Letter to the Editor]
25/9/2017
Albert J. Yoo, Osama O. Zaidat, Rudiger von Kummer
ver resumen

Letter by Malhotra et al Regarding Article, “Neurons Over Nephrons: Systematic Review and Meta-Analysis of Contrast-Induced Nephropathy in Patients With Acute Stroke” [Letter to the Editor]
25/9/2017
Ajay Malhotra, Xiao Wu, Long H. Tu
ver resumen

Response by Brinȷikȷi to Letter Regarding Article “Neurons Over Nephrons: Systematic Review and Meta-Analysis of Contrast-Induced Nephropathy in Patients With Acute Stroke” [Letter to the Editor]
25/9/2017
Waleed Brinjikji
ver resumen

Letter by Kunz et al Regarding Article, “Systematic Review of the Cost and Cost-Effectiveness of Rapid Endovascular Therapy for Acute Ischemic Stroke” [Letter to the Editor]
25/9/2017
Wolfgang G. Kunz, Kolja M. Thierfelder, M.G. Hunink
ver resumen

Letter by Spence Regarding Article, “Antiplatelet Regimen for Patients With Breakthrough Strokes While on Aspirin: A Systematic Review and Meta-Analysis” [Letter to the Editor]
25/9/2017
J. David Spence
ver resumen

Response by Lee and Ovbiagele to Letter Regarding Article, “Antiplatelet Regimen for Patients With Breakthrough Strokes While on Aspirin: A Systematic Review and Meta-Analysis” [Letter to the Editor]
25/9/2017
Meng Lee, Bruce Ovbiagele
ver resumen

Letter by Lederer et al Regarding Article, “Interfacility Transfer Directly to the Neuroangiography Suite in Acute Ischemic Stroke Patients Undergoing Thrombectomy” [Letter to the Editor]
25/9/2017
Wolfgang Lederer, Michael Baubin, Franz J. Wiedermann
ver resumen

Response by Jadhav et al to Letter Regarding Article, “Interfacility Transfer Directly to the Neuroangiography Suite in Acute Ischemic Stroke Patients Undergoing Thrombectomy” [Letter to the Editor]
25/9/2017
Ashutosh P. Jadhav, Tudor G. Jovin
ver resumen

Letter by Braillon Regarding Article, “Contribution of Established Stroke Risk Factors to the Burden of Stroke in Young Adults” [Letter to the Editor]
25/9/2017
Alain Braillon
ver resumen

Response by Aigner et al to Letter Regarding Article, “Contribution of Established Stroke Risk Factors to the Burden of Stroke in Young Adults” [Letter to the Editor]
25/9/2017
Annette Aigner, Markus A Busch, Ulrike Grittner
ver resumen

Letter by Sallustio et al Regarding Article, “Endovascular Thrombectomy and Stroke Physicians: Equity, Access, and Standards” [Letter to the Editor]
25/9/2017
Fabrizio Sallustio, Alessandro Davoli, Giacomo Koch
ver resumen

Correction to: Plasma Magnesium and Risk of Ischemic Stroke Among Women [Correction]
25/9/2017
ver resumen

Correction to: Natural History of Perihematomal Edema and Impact on Outcome After Intracerebral Hemorrhage [Correction]
25/9/2017
ver resumen







Feed aggregation powered by Syndicate Press.
Processed request in 0.21007 seconds.